Keyphrases
Alzheimer's Disease
100%
Disease-modifying Therapy
100%
Scientific Community
25%
Multi-target
25%
Disease Pathogenesis
25%
Disease Process
25%
Placebo
25%
Multiple Mechanisms
25%
Moderate to Severe
25%
Oxidative Stress
25%
Patient Benefit
25%
Traditional Science
25%
Treatment Group
25%
Systems Biology Approach
25%
Lesional
25%
Phase III Clinical Trial
25%
Avail
25%
Moderate Disease
25%
Late Failure
25%
Negative Data
25%
Tau Phosphorylation
25%
Amyloid Metabolism
25%
Amyloid Cascade Hypothesis
25%
Bapineuzumab
25%
Biochemistry, Genetics and Molecular Biology
Amyloid Protein
100%
Metabolic Pathway
50%
Tau
50%
Clinical Trial
50%
Mediator
50%
Oxidative Stress
50%
Immunology and Microbiology
Mediator
100%
Oxidative Stress
100%
Bapineuzumab
100%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Alzheimer's Disease
100%
Amyloid Protein
28%
Clinical Trial
14%
Placebo
14%
Side Effect
14%
Bapineuzumab
14%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
50%
Oxidative Stress
25%
Metabolic Pathway
25%
Placebo
25%
Bapineuzumab
25%
Agricultural and Biological Sciences
Amyloid Protein
100%
Biological Sciences
50%
Placebo
50%
Oxidative Stress
50%